1 results match your criteria: "Bio-process Development Center[Affiliation]"
J Biosci Bioeng
November 2005
Bio-process Development Center, Aventis Pharma Ltd., 3-2 Minamidai 1-chome, Kawagoe, Saitama 350-1165, Japan.
An efficient downstream process for the production of recombinant human growth differentiation factor 5 (rhGDF5) has been developed for industrial application utilizing a novel "direct refolding" method. In this method, the starting material is an inclusion body produced in Escherichia coli, and the critical step is the direct refolding step that follows directly after solubilization of the inclusion body. rhGDF5 can be refolded at a markedly high concentration of 2.
View Article and Find Full Text PDF